Secretary of Health and Human Services - 101

U.S. Secretary of Health and Human Services, Robert F. Kennedy Jr., has been at the center of several significant developments in recent days. One of the most notable changes involves a shift in the rule-making process within the Department of Health and Human Services. On March 3, 2025, Secretary Kennedy announced that HHS will no longer be required to open new rules and regulations for public comment before implementation. This decision rescinds the Richardson Waiver, a policy that has been in place since 1971 and mandated notice-and-comment periods beyond those required by the Administrative Procedure Act. The new policy aligns HHS rulemaking procedures with the APA, but critics argue that it reduces transparency and public participation in decision-making processes that affect public health and welfare[4].

In another significant move, HHS has amended its rule-making process to grant Secretary Kennedy more discretion and reduce administrative hurdles. The department will no longer use notice-and-comment rulemaking procedures for matters related to agency management, personnel, public property, loans, grants, benefits, or contracts, unless otherwise required by law. This change is expected to enhance the department's flexibility but has raised concerns about reduced transparency and public input[2][4].

Secretary Kennedy has also been involved in updates to the Dietary Guidelines for Americans. Along with U.S. Secretary of Agriculture Brooke Rollins, he announced continued work on the 2025-2030 Dietary Guidelines. The public comment period closed on February 10, 2025, and HHS and USDA are currently reviewing the Scientific Report of the 2025 Dietary Guidelines Advisory Committee. The secretaries emphasized their commitment to ensuring the guidelines are based on sound science and serve public health rather than special interests[1].

Additionally, Secretary Kennedy's leadership has been marked by controversy, particularly regarding his views on vaccines. Despite facing questions about his past remarks on vaccine efficacy during his confirmation hearings, he was confirmed by the Senate in a 52-48 vote. His tenure has seen the cancellation of a meeting at the FDA to discuss next season's flu vaccines, although HHS has assured that the flu shots will still be available[3].

The department has also made changes to its policies on gender-affirming care. The Office for Civil Rights (OCR) at HHS rescinded prior guidance on civil rights and health information privacy for transgender youth, aligning with Executive Orders aimed at protecting children from what the administration describes as "chemical and surgical mutilation"[2].

In a broader context, Secretary Kennedy's department is undergoing significant restructuring, including a voluntary buyout offer of $25,000 to all HHS employees, which has been seen as a move to reshape the department's workforce and policy direction[3].

These developments highlight the significant changes and challenges facing the Department of Health and Human Services under Secretary Robert F. Kennedy Jr.'s leadership, with a focus on streamlining processes, updating health guidelines, and implementing new policies that reflect the current administration's priorities.

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. has been at the forefront of several significant developments in the last few days, reflecting a marked shift in the department's policies and procedures.

One of the most notable changes involves the rule-making process within HHS. On March 3, 2025, Secretary Kennedy announced the rescission of the Richardson Waiver, a policy that had been in place since 1971. This waiver required new rules and regulations to be open for public comment before implementation, a practice that went beyond the requirements of the Administrative Procedure Act (APA). The new policy aligns HHS rulemaking procedures with the APA, eliminating the mandatory public comment period for certain types of rules, such as those related to agency management, personnel, public property, loans, grants, benefits, or contracts. This change is expected to grant Secretary Kennedy more discretion and reduce administrative hurdles, although it has been met with criticism from those who value public transparency and participation[2][4].

In addition to this procedural change, Secretary Kennedy and U.S. Secretary of Agriculture Brooke Rollins have been working on the 2025-2030 Dietary Guidelines for Americans. Following the inaugural meeting of the Make America Healthy Again Commission, they announced their commitment to releasing the final guidelines ahead of the statutory deadline of December 31, 2025. The guidelines are currently under a line-by-line review of the Scientific Report of the 2025 Dietary Guidelines Advisory Committee. Both secretaries emphasized the importance of basing the guidelines on sound science rather than political ideologies, with a focus on promoting healthy choices and outcomes[1].

Another significant decision made by Secretary Kennedy involves the rescission of prior guidance related to gender-affirming care for transgender youth. The HHS Office for Civil Rights (OCR) rescinded the 2022 guidance on civil rights and health information privacy for transgender youth, aligning with Executive Orders 14187 and 14168. This move reflects a shift in the administration's policy, with HHS now stating it will not promote, assist, or support gender-affirming care for children[2].

These changes underscore a broader effort by the current administration to reshape health and human services policies. Secretary Kennedy's "Make America Healthy Again" agenda has been a central theme since his appointment, with a focus on transforming federal health guidance and promoting policies that align with the administration's vision for public health[5].

Secretary of Health and Human Services Robert F. Kennedy Jr. has been at the center of several significant developments in recent days, reflecting a marked shift in the department's policies and operations.

One of the most notable changes involves the rule-making process within the Department of Health and Human Services. Secretary Kennedy has announced a policy to limit public participation in HHS decision-making by rescinding the long-standing Richardson Waiver. This waiver had allowed for broader public input on agency rules related to grants, loans, benefits, and contracts, going beyond the narrow requirements of the Administrative Procedure Act (APA). With the waiver rescinded, HHS agencies and offices now have the discretion to apply notice and comment procedures to these matters but are not obligated to do so unless mandated by law. This move has sparked concerns among legal experts and advocates, who fear it could reduce transparency and public engagement in policy decisions[1][4].

In another significant move, the Office for Civil Rights (OCR) within HHS has rescinded prior guidance on civil rights and health information privacy for transgender youth. The 2022 OCR Notice and Guidance, which outlined the application of federal civil rights and patient privacy laws to support transgender medical interventions, no longer represents the views or policies of HHS OCR. This decision aligns with Executive Orders 14187 and 14168, which aim to protect children from certain medical procedures and defend women from what is termed "gender ideology extremism"[1].

Additionally, all employees of the Department of Health and Human Services were recently offered a voluntary separation incentive payment of $25,000 to resign. This offer is part of the Trump administration's broader effort to reduce the federal workforce and shrink the government's budget. The move follows similar buyouts offered to employees in other federal agencies, such as the Social Security Administration. This initiative is led by the Department of Government Efficiency, headed by billionaire Elon Musk, and has resulted in significant job cuts across various federal agencies[2][3].

Secretary Kennedy's leadership has also been marked by controversy, particularly regarding his views on vaccines. Despite facing intense scrutiny during his confirmation hearings for his past statements on vaccine efficacy, Kennedy was confirmed by the Senate in a 52-48 vote. His tenure is expected to be challenging, especially given the ongoing health issues such as the bird flu outbreak and a measles outbreak that has claimed lives[2].

The Department of Health and Human Services, under Kennedy's leadership, is also taking actions to support President Trump's executive orders, particularly those related to defending women and children and restoring the concept of biological truth in federal policies. These actions reflect a broader alignment with the administration's policy directives[5].

In summary, Secretary Robert F. Kennedy Jr.'s tenure at HHS has been characterized by significant policy changes, controversies, and administrative shifts, all of which are shaping the department's approach to public health and policy-making.

Secretary of Health and Human Services Robert F. Kennedy Jr. has been at the center of several significant developments in the last few days, marking a substantial shift in the department's policies and operations.

One of the most notable changes is the rescission of the long-standing Richardson Waiver, which had required the Department of Health and Human Services (HHS) to go beyond the minimum public comment requirements outlined in the Administrative Procedure Act (APA). Effective immediately, HHS will no longer be mandated to open new rules and regulations to public comment before implementation, unless otherwise required by law. This move, announced on February 28 and formally published in the Federal Register on March 3, 2025, grants HHS agencies more discretion and reduces administrative hurdles, but it has also raised concerns about transparency and public participation in decision-making processes[2][5].

In another significant move, HHS Secretary Robert F. Kennedy Jr. has offered a voluntary separation package to most of the department's 80,000 employees, providing up to a $25,000 payment for those who choose to leave their positions. This initiative is part of a broader effort by the Trump administration, aided by billionaire Elon Musk, to cut costs and reduce the federal workforce. The offer comes as HHS is involved in critical public health issues, such as addressing a measles outbreak in West Texas and New Mexico, and as lawmakers debate deep cuts to Medicaid in the federal budget[4].

Additionally, Kennedy has made headlines with his stance on various health policies. The Office for Civil Rights (OCR) within HHS has rescinded prior guidance on civil rights and health information privacy for transgender youth, aligning with recent executive orders aimed at limiting gender-affirming care for children. This decision reflects a shift in HHS policy under Kennedy's leadership, emphasizing a more restrictive approach to transgender medical interventions[1].

Kennedy's influence on health policy is further underscored by his controversial past remarks, particularly on vaccines. Despite these controversies, he was confirmed by the Senate as the Secretary of Health and Human Services in a 52-48 vote. His confirmation and subsequent actions have highlighted the challenges he faces in balancing his personal views with the responsibilities of his role in leading a critical federal health agency[3].

These recent developments indicate a significant reorientation of HHS policies and practices under Secretary Kennedy's leadership, with a focus on administrative efficiency, reduced public input, and alignment with the current administration's health policy directives. As these changes unfold, they are likely to have profound implications for the department's operations and the broader healthcare landscape in the United States.

U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has made a significant policy change that has sparked considerable debate and concern. On February 28, 2025, Secretary Kennedy issued a policy statement announcing the rescission of the Richardson Waiver, a long-standing policy that had required HHS to allow public comment on new rules and regulations beyond the minimum requirements of the Administrative Procedure Act (APA).

This waiver, in place since 1971, had mandated that HHS provide the public with an opportunity to comment on proposed rules, including those related to agency management, personnel, public property, loans, grants, benefits, and contracts. The decision to rescind this waiver was formally published in the Federal Register on March 3, 2025.

According to the policy statement, the Richardson Waiver imposed "extra-statutory obligations" that were seen as a burden on the department, contrary to its efficient operation, and impeding its flexibility to adapt quickly to legal and policy mandates. Secretary Kennedy argued that these obligations were beyond the maximum procedural requirements specified in the APA and thus were no longer necessary[1][2][4].

This move has been met with criticism from various stakeholders, including advocacy groups and legal experts. They argue that public comment is crucial for transparency and ensuring that the public has a voice in rule-making decisions that affect health and welfare. LeadingAge President and CEO Katie Smith Sloan expressed concern that this change could have negative impacts on policies related to payment, regulations, safety, and operations[2].

The new policy aligns HHS rulemaking procedures with the APA, which does not require public comment for certain categories such as agency management, personnel, public property, loans, grants, benefits, or contracts. However, HHS agencies and offices still have the discretion to apply notice and comment procedures if they choose to do so[2][4].

This decision is particularly significant as it contradicts Secretary Kennedy’s earlier pledges of “radical transparency” in public health decision-making. The change may affect various areas, including Medicare, Medicaid, and the Children's Health Insurance Program, although changes to Medicare are likely to still require public notice and comment due to separate statutory requirements[4].

Industry experts are also questioning the scope of policies that will now be exempt from public comment and the potential impact on the practical implementation and judicial review of these rules. For instance, HHS contracts and grants may largely see a departure from notice and comment procedures, which could lead to less certainty in the interpretation of rules applicable to these areas[4].

Overall, the rescission of the Richardson Waiver marks a significant shift in how HHS engages with the public in its rule-making processes, raising concerns about transparency and public participation in health policy decisions.

U.S. Secretary of Health and Human Services, Robert F. Kennedy Jr., has been at the center of several significant and contentious developments in the last few days. One of the most notable actions taken by Secretary Kennedy is the decision to limit public participation in the Department of Health and Human Services (HHS) decision-making process.

On February 28, 2025, Kennedy issued a policy statement that rescinds the long-standing Richardson Waiver, which had allowed for public input on HHS rules regarding grants, loans, benefits, and contracts beyond the minimum requirements of the Administrative Procedure Act (APA). This move effectively ends the mandatory public comment period for many HHS rulemaking processes, citing that these "extra-statutory obligations" impose costs and inefficiencies on the department[2][5].

This decision is particularly striking given Kennedy's earlier pledges of "radical transparency" during his confirmation hearings. Critics argue that this new policy contradicts his promises and could reduce public trust in HHS, which is already a concern following controversies over COVID-19 and other health issues[5].

In another significant move, Kennedy has been involved in the response to a measles outbreak in Texas. As the outbreak has grown to 159 cases, with the majority of those affected being unvaccinated or of unknown vaccination status, Kennedy has faced criticism for his approach. Instead of emphasizing vaccination, Kennedy has promoted unconventional treatments such as cod liver oil and vitamin A, which has raised concerns among public health experts. They fear this approach may distract from the critical importance of vaccination in preventing the spread of measles[1][4].

Additionally, Kennedy's leadership is tied to the newly established "Make America Healthy Again Commission," launched by President Donald Trump. This commission, chaired by Kennedy, aims to investigate the causes of the long-term increase in chronic illnesses and deliver an action plan to address these issues. The commission is also tasked with increasing transparency in federally funded health research and establishing a framework for transparency and ethics in industry-funded projects[4].

The Trump administration, under which Kennedy serves, has also made headlines with its stance on abortion rights. The administration has dropped a legal battle with Idaho over emergency abortions, reversing a stance inherited from the Biden administration. Furthermore, the Trump administration has sought to join oral arguments in a case involving South Carolina's attempt to block Medicaid funding for Planned Parenthood, further highlighting the administration's stance on abortion[1].

These recent actions and decisions underscore the significant impact Secretary Kennedy and the Trump administration are having on public health policy and the broader healthcare landscape. As these developments continue to unfold, they are likely to remain under intense scrutiny from public health experts, legal analysts, and the general public.

In recent days, the U.S. Department of Health and Human Services (HHS) has been at the center of significant developments, largely driven by the actions and leadership style of its new Secretary, Robert F. Kennedy Jr.

On February 28, 2025, Secretary Kennedy issued a policy statement that has sparked considerable controversy and concern within the health care industry and beyond. This statement rescinds a long-standing waiver known as the Richardson Waiver, which had required HHS to undergo the Administrative Procedure Act’s (APA) notice-and-comment rulemaking process for rules related to agency management, personnel, public property, loans, grants, benefits, or contracts. By rescinding this waiver, HHS is no longer obligated to seek public input on these types of rules, unless otherwise mandated by law[1][4].

This decision has raised alarms among legal experts and advocates, as it contradicts Secretary Kennedy’s earlier pledges of “radical transparency.” The move is seen as potentially limiting public participation in HHS decision-making, which could have far-reaching implications for health care policies, including those related to grants, loans, benefits, and contracts. Organizations such as LeadingAge have expressed concern that this change could negatively impact critical areas such as payment, regulations, safety, and operations[4].

The implications of this policy statement are particularly nuanced when it comes to federal health benefit programs. While the statement does not apply to Medicare policies, which are subject to independent rulemaking requirements under the Social Security Act, it could potentially affect rules governing Medicaid and other federal health benefit programs. However, the extent to which HHS will interpret and apply this exemption remains unclear[1].

In addition to this policy change, Secretary Kennedy’s leadership style and certain stances on health issues have also been under scrutiny. His controversial views on vaccines, for instance, have been a subject of debate. Despite extensive research showing that vaccines do not cause autism, Kennedy has promoted the idea that vaccines are unsafe and ineffective. These views are at odds with the scientific consensus and have raised concerns about the direction of public health policy under his leadership[2].

Internal tensions within HHS have also come to the forefront. On March 3, 2025, Thomas Corry, the U.S. assistant secretary of public affairs, announced his resignation due to internal clashing over Kennedy’s management style and the escalating health emergencies, including a growing measles outbreak. This resignation highlights the internal strife and challenges facing the department under Kennedy’s leadership[3].

Overall, the recent actions and decisions of Secretary Robert F. Kennedy Jr. have introduced significant changes and uncertainties within the Department of Health and Human Services, prompting close monitoring from various stakeholders and raising questions about the future of health care policy and public health initiatives.

Following President Donald Trump's re-inauguration on January 20, 2025, the Department of Health and Human Services (HHS) has undergone significant personnel and policy changes. One of the key changes is the appointment of Dr. Dorothy Fink as the Acting Secretary of HHS, replacing Xavier Becerra, who served under President Biden. However, President Trump's nominee for the permanent HHS Secretary position is Robert F. Kennedy Jr., who has recently been sworn in despite awaiting formal Senate confirmation[1][3][4].

Robert F. Kennedy Jr.'s appointment has been marked by controversy, particularly due to his stance on vaccines. Kennedy has been a vocal critic of vaccine safety, despite extensive scientific evidence showing that vaccines do not cause autism. His views have sparked concerns among health experts and the public, as they could potentially undermine public health initiatives[3].

In his new role, Kennedy has outlined ambitious plans, including the establishment of a presidential commission to investigate the rise in chronic illnesses among children and young adults. This commission, chaired by Kennedy, aims to identify the causes of these health issues and develop an action plan to address them. The initiative is part of a broader "Make America Healthy Again" platform, which includes goals such as restoring what Kennedy terms "gold standard science" at agencies like the NIH, FDA, and CDC, and eliminating conflicts of interest within these organizations[3][4].

One of Kennedy's first significant decisions as HHS Secretary has been to alter the public comment process for rulemaking. He has issued a policy statement indicating that HHS will no longer be required to undergo public comment periods for proposed rulemaking in certain areas, such as agency management, personnel, public property, loans, grants, benefits, or contracts. This move is seen as a departure from traditional transparency and public engagement practices, despite Kennedy's earlier promises of increased transparency in public health policy[5].

Additionally, HHS has recently proposed amendments to the HIPAA Security Rule to enhance the cybersecurity of electronic protected health information (ePHI). These proposed changes, published in December 2024, aim to address modern breach and cybersecurity risks, incorporate industry best practices, and correct common deficiencies observed in compliance investigations. However, the fate of these amendments is uncertain due to a regulatory freeze imposed by President Trump following his re-inauguration[2].

Another notable change within HHS is the appointment of Anthony Archeval as the Acting Director of the HHS Office for Civil Rights (OCR). Archeval, who previously served as the Diversity and Inclusion Director for the Health Resources and Services Administration during Trump's first term, will oversee significant policy and regulatory changes within the OCR[1].

These developments highlight the significant shifts in leadership and policy direction at HHS under the new administration, with potential far-reaching impacts on public health, regulatory processes, and the overall functioning of the department.

Robert F. Kennedy, Jr. was sworn in as the 26th Secretary of the U.S. Department of Health and Human Services (HHS) on February 13, 2025, following a Senate vote of 52-48 that confirmed his nomination. This confirmation came after the Senate Finance Committee voted along party lines to advance his nomination to the full Senate[2][4].

Kennedy's appointment is marked by significant controversy, particularly due to his outspoken views on health issues. One of the most contentious aspects of his stance is his criticism of vaccines, where he has promoted the debunked idea that vaccines cause autism and other conditions. Extensive scientific research has conclusively shown that vaccines do not cause autism, and the original claims behind these assertions were retracted due to ethical violations and professional misconduct[3].

Despite these controversies, Kennedy has been given a broad mandate by President Trump, who has publicly stated that he will allow Kennedy to "go wild" on his ideas. This includes pushing through a sweeping "Make America Healthy Again" platform, which could have far-reaching implications for health policies in the United States[3].

As HHS Secretary, Kennedy has substantial authority to establish regulations governing health, including food and drug safety, public health, and healthcare quality. He can also declare public health emergencies and coordinate federal responses to health crises such as disease outbreaks or natural disasters. Kennedy's influence extends over key agencies like the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH)[3].

In conjunction with Kennedy's swearing-in, President Trump signed an executive order titled "Make America Healthy Again," which is part of a broader initiative aimed at reshaping health policies in the country. This executive order is expected to align with Kennedy's policy priorities, although the specific details and implications are yet to be fully outlined[1].

Kennedy's tenure is also set against the backdrop of other significant health-related developments. For instance, the NIH recently issued guidance capping indirect cost rates for NIH award recipients at 15%, a move that has been met with opposition from various stakeholders, including hospitals and lawmakers from both parties[4].

Additionally, the Trump administration has been filling out other key healthcare positions, including nominations for assistant secretaries at HHS and the administrator of the U.S. Drug Enforcement Administration. These nominations will need Senate confirmation to proceed[4].

Overall, Robert F. Kennedy, Jr.'s appointment as HHS Secretary and the accompanying executive order by President Trump signal a potentially significant shift in health policy in the United States, with Kennedy's controversial stances likely to be a focal point of ongoing debates and policy discussions.

Robert F. Kennedy Jr. has been confirmed as the Secretary of the Department of Health and Human Services (HHS) in a closely divided Senate vote of 52-48, largely along party lines. This confirmation has set the stage for significant changes in the nation's health policies, aligning with Kennedy's "Make America Healthy Again" agenda.

Kennedy, a longtime vaccine skeptic and critic of processed foods, has been a contentious figure due to his history of spreading conspiracy theories, including false statements about vaccines and their alleged link to autism. Despite these controversies, he has garnered support for his pledges to promote healthier foods, tackle pollution, address the root causes of chronic diseases, and ban prescription drug ads[1][2][4].

The confirmation process was marked by intense hearings and tense committee votes. Senator Mitch McConnell, a Republican from Kentucky and a polio survivor, was the lone Republican to oppose Kennedy's nomination, citing his decades-long opposition to vaccines. Other Republicans, such as Senator Bill Cassidy of Louisiana, a physician, initially expressed reservations but ultimately voted to confirm Kennedy after he assured them he would work within existing vaccine approval and safety systems[1][4].

As HHS Secretary, Kennedy will oversee a vast portfolio that includes the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), and the Centers for Medicare and Medicaid Services (CMS). The HHS has a budget of nearly $2 trillion, making it one of the federal government's largest agencies[2].

Kennedy's tenure is expected to bring a shakeup in health care policies. He has promised to tackle the rising incidence of chronic diseases and take aim at over-processed foods contributing to obesity. However, his plans for major healthcare programs like Medicare and Medicaid remain unclear, with some concerns raised during confirmation hearings about his understanding of these programs[1][4].

Additionally, Kennedy has signaled a willingness to restrict abortion, despite his prior support for a woman's right to choose. He has stated that he will follow President Donald Trump's lead on abortion policy, which may include further scrutiny of mifepristone, the medication used in abortion procedures[4].

The appointment of Kennedy as HHS Secretary has been met with strong opposition from many in the public health community, who are concerned about his qualifications and the potential impact of his policies on public health. Nevertheless, with his confirmation, Kennedy is now poised to implement his vision for the nation's health, which will be closely watched by both supporters and critics.